Open Access

The role of CT in PET/CT for assessing diffuse infiltration of bone marrow in multiple myeloma using the Durie‑Salmon PLUS staging system

  • Authors:
    • Tiantian Wang
    • Xin Peng
    • Wenli Qiao
    • Yan Xing
    • Jiqin Yang
    • Jinhua Zhao
  • View Affiliations

  • Published online on: April 30, 2020     https://doi.org/10.3892/mco.2020.2039
  • Pages: 13-18
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

PET/CT has been identified as one of the routine methods for the assessment of multiple myeloma (ΜΜ) bone marrow infiltration. In the routine method of performing PET/CT, the 18F-Fludeoxyglucose (18F‑FDG) uptake in this disease is often used in the assessment of this condition, however CT diagnosis is not currently commonly used. The aim of the present study was to investigate the importance of CT in PET/CT for assessing diffuse infiltration (DI) of bone marrow in ΜΜ. MRI was used as a control in the present study, which is the gold standard for assessing DI of bone marrow and is divided into 3 levels: Mild, moderate and severe DI. Subsequently, a total of four combinations of PET and CT results were listed using the enumeration method for the evaluation of DI in the bone marrow. These combinations were respectively compared with the three levels of MR imaging to screen the most consistent method. The concordances of the new method and routine 18F‑FDG PET/CT for the assessment of DI with MR imaging were compared using the McNemar test, respectively. The results of the DI assessment from the two methods were verified by performing Durie‑Salmon (D-S) PLUS staging. Compared with MR imaging, the results were as follows: PET and CT exhibited negative results, suggesting mild DI; one of them was positive, suggesting moderate DI; and two were positive, suggesting severe DI. The results of concordance between two methods (new and routine) and MR imaging are indicated as follows: For the new method, McNemar test, P=0.513 and Kappa=0.745; for the routine 18F‑FDG PET/CT method, McNemar test, P=0.03 and Kappa=0.547. Re‑performance of D‑S PLUS staging presented the following results: New method, McNemar test, P=0.317 and Kappa=0.93; for the routine method, McNemar test, P=0.223 and Kappa=0.811. These findings indicated that the CT component of PET/CT could improve the concordance with MRI results in the assessment of DI, and the same results were obtained when D‑S PLUS staging was performed. The CT in PET/CT can enhance diagnostic accuracy in the assessment of DI by reducing the false negatives when compared with the routine 18F‑FDG method.

Related Articles

Journal Cover

July 2020
Volume 13 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, T., Peng, X., Qiao, W., Xing, Y., Yang, J., & Zhao, J. (2020). The role of CT in PET/CT for assessing diffuse infiltration of bone marrow in multiple myeloma using the Durie‑Salmon PLUS staging system. Molecular and Clinical Oncology, 13, 13-18. https://doi.org/10.3892/mco.2020.2039
MLA
Wang, T., Peng, X., Qiao, W., Xing, Y., Yang, J., Zhao, J."The role of CT in PET/CT for assessing diffuse infiltration of bone marrow in multiple myeloma using the Durie‑Salmon PLUS staging system". Molecular and Clinical Oncology 13.1 (2020): 13-18.
Chicago
Wang, T., Peng, X., Qiao, W., Xing, Y., Yang, J., Zhao, J."The role of CT in PET/CT for assessing diffuse infiltration of bone marrow in multiple myeloma using the Durie‑Salmon PLUS staging system". Molecular and Clinical Oncology 13, no. 1 (2020): 13-18. https://doi.org/10.3892/mco.2020.2039